Cancer drug tested to tame sickle Cell's agony
NCT ID NCT03997903
Summary
This small, early-stage study tested whether imatinib, a drug used for certain cancers, could help control sickle cell disease. It aimed to see if taking the pill daily for six months would reduce the frequency of severe pain episodes and other complications in young adults. The study also measured changes in the patients' red blood cells to understand how the drug might be working.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Children's Hospital
Cincinnati, Ohio, 45229, United States
-
Riley Hospital for Children at IU Health
Indianapolis, Indiana, 46202, United States
Conditions
Explore the condition pages connected to this study.